2 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Completed 2, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo. Group A recieving PUVA therapy, Group B receiving Tablet Tofacitinib - Vitiligo, Generalized | Early Phase 1 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 64 | 2026-06-01 | 2026-01-30 |
| Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo Microneedling with 5-fluorouracil, Topical application of 0.05% Clobetasol propionate - Vitiligo | Early Phase 1 | Recruiting | Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan | 40 | 2025-08-08 | 2026-02-17 |
| COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO Tacrolimus, Calcipotriol - Vitiligo - Macular Depigmentation, Tacrolimus | Early Phase 1 | Enrolling by invitation | Dr ayesha wahid | 60 | 2025-05-01 | 2025-06-24 |
| Role of Tofacitinib in Vitiligo Patients JAK-2 inhibitor, Topical corticosteroid - Vitiligo, Effect of Drug | Early Phase 1 | Unknown | Pi Research Consultancy Center, Bangladesh | 80 | 2022-05-30 | 2022-03-24 |
| Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment Bimatoprost, Excimer laser, Microneedling with a dermaroller - Vitiligo | Early Phase 1 | Completed | Medical University of South Carolina | 4 | 2021-11-02 | 2022-08-05 |
| Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo Tildrakizumab - Skin and Connective Tissue Diseases, Skin Diseases | Early Phase 1 | Completed | Premier Specialists, Australia | 12 | 2021-09-16 | 2024-11-12 |
Hypopigmentation (1) · Pigmentation Disorders (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Hypopigmentation (5) · Pigmentation Disorders (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Percutaneous Collagen Induction (2) · Adrenal Cortex Hormones (1) · Bimatoprost (1) · Clobetasol (1) · Fluorouracil (1) · Lasers, Excimer (1) · Tacrolimus (1) · calcipotriene (1) · tildrakizumab (1) · tofacitinib (1)
Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan (1) · Dr ayesha wahid (1) · Hayat Abad Medical Complex, Peshawar (1) · Medical University of South Carolina (1) · Pi Research Consultancy Center, Bangladesh (1) · Premier Specialists, Australia (1)
Pakistan (3) · Australia (1) · United States (1)
Dedee Murrell, MD (1) · Mohammad Jahid Hasan, MPH (1)